In view of case reports and evidence that colorectal cancer risks are higher for patients with SMAD4 mutations, we were surprised that the risk of colorectal cancer did not emerge more strongly for participants and/or relatives with HHT. This evidence concerns the gene SMAD4 and colorectal cancer.